Bristol-Myers Squibb (BMY)
$46.58
1.28 (2.67%)
BMY Stock Quote Delayed 15 Minutes
Previous Close
$46.58
Market Cap
76.14B
PE Ratio
81.72
EPS
0.57
Volume (Avg. Vol.)
16.32M
Day's Range
46.29 - 48.20
52-Week Range
42.48 - 63.69
Dividend & Yield
1.60 (3.43%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
Bristol-Myers Squibb Stock Has Upside — But Mind the Risks
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
Risk-Takers Have a Reasonable Shot with BMY Stock
Political pressures regarding drug pricing and Bristol-Myers’ disappointing clinical trails have contributed to a disappointing performance for BMY stock. Still, much of this bearishness could be priced in already.
Fear Around Bristol-Myers Squibb Stock is Starting to Fade
BMY stock may continue to bounce around, but the months-long selloff is now slowing because Bristol-Myers Squibb is still thriving.
Stock Market Today: The Tariff Man Is Back
Investors were looking at a strong rally in the stock market today, until the president tweeted about incoming tariff increases against China.
Stock Market Today: Boeing, Tesla Tumble on More Worries
Stock were hit on Thursday as investors try to parse through a deluge of earnings results. Here's what moved the stock market today.
Bristol-Myers Squibb Earnings: BMY Stock Bounces on Strong Q2, Guidance
Bristol-Myers Squibb earnings for the second quarter of the year have BMY stock on the move Thursday after it beat estimates.
Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
4 Drug Stocks Getting Smashed
Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.
Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?
Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.
5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.
3 Big Stock Charts for Tuesday: MGM Resorts, Electronic Arts and Advance Auto Parts
The stock charts of EA, AAP and MGM have run through the technical trading wringer in front of today's action.
Nasdaq Today: Celgene, Ulta, Caesars’ Buyout
Celgene and Bristol-Myers Squibb stocks took a hit, video games rallied and Caesars Entertainment entered into a $17.3 billion merger. Here's the Nasdaq Today report.
5 Top Stock Trades for Tuesday: CELG, BMY, CZR
Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.
Bristol-Meyers Squibb News: Why BMY Stock Is Falling Today
Bristol-Meyers Squibb news for Monday has BMY stock taking a beating after announcing a delay to its merger deal with Celgene.
2 Dividend Stocks to Buy That Are Better Than 3M Stock
MMM stock has fallen 25% in the past six weeks since announcing weaker-than-expected Q1 earnings. 3M stock has been weak since then.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
